ArticleFrontiers in immunology2026
Clinical application of deep learning-based measurement of glomerular morphometry in IgAN.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate glomerular pathology assessment is crucial for predicting outcomes and guiding treatment in IgA nephropathy (IgAN). Although the Oxford classification provides a standardized histological assessment, it is semi-quantitative and subjective. Identifying objective and interpretable renal pathological features could enhance prognostic prediction. Methods: We developed and validated a deep learning-based computational pathology pipeline for glomerular analysis in IgAN. A glomerular segmentation and classification model was developed based on deep convolutional neural networks in 183 periodic acid-Schiff (PAS)-stained whole slide images (WSIs) of renal pathology from IgAN patients, and was further applied to WSIs of 886 IgAN patients from a prospective cohort. Associations of glomerular morphometry with clinical phenotypes and prognosis were determined. Results: The models demonstrated glomerular segmentation performance with a Dice coefficient of 0.91 and classification performance with an AUC of 0.94. Through a comprehensive correlation analysis of quantitative morphometric characteristics and clinical parameters, we found that age, gender, and body mass index significantly influenced glomerular morphology. No association was found between proteinuria and glomerular size. Notably, a nonlinear relationship was observed between glomerular size and estimated glomerular filtration rate (eGFR), with patients having an eGFR between 30 and 60 ml/min/1.73m Conclusions: In conclusion, we developed an end-to-end pipeline for glomerular segmentation, classification, and morphometry in WSIs. These objective and highly reproducible quantitative characteristics of glomeruli may serve as a valuable tool for therapeutic guidance and prognostic assessment in IgAN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.